Press center
Career
Contacts
Menu
Group of companies
About GEROPHARM Group
Mission and values
History
News
At GEROPHARM, our main goal is to help people preserve their health.
Products
Product portfolio
Pharmacovigilance
GEROPHARM is main expertise lies within CNS, ophthalmology and endocrinology. New products are now being developed in other areas as well.
Research and Development
Scientific researches
Product Pipeline
Scientific publications
International scientific cooperation
At GEROPHARM, we achieve success through combination of cutting edge technology, world’s best practices and experience of our unique team.
Production
Technological platform
Quality management
Opening of GEROPHARM-Bio plant
At GEROPHARM, we created the flexible full cycle production platform which constantly provides required output of invariably high quality.
To partners
International cooperation
Export sales development
Contacts
GEROPHARM is open for building mutually beneficial partnerships in Russia and abroad. Learn more about business development opportunities.
Corporate Social Responsibility
Corporate Social Responsibility
Corporate Social responsibility is one of the key strategic priorities of GEROPHARM as we build out future together with the patients community.
Main
Group of companies
News
News
2016
2015
2014
2013
2012
2011
2010
31 March
The head of GEROPHARM became the member of the Expert Council of the State Duma Committee
31 March
PharmEvolution 2016: evolution of technologies, competences and ideas of current capabilities of the Russian industry
29 March
GEROPHARM at the awarding ceremony of the All-Russian competition "Leader of the Russian Business"
25 March
GEROPHARM discussed the dynamics of import substitution at the forum "GOSZAKAZ - FOR fair purchases"
23 March
GEROPHARM continues to expand its pipeline of antidiabetic drug products
22 March
VTB finances the construction of GEROPHARM's pharmaceutical plant in St. Petersburg
21 March
Pregabalin produced by GEROPHARM - a new domestic alternative to the original drug
17 March
GEROPHARM launches a new educational website devoted to a subject of climax
16 March
GEROPHARM’s press index is among top 20 industry leaders in Russia
15 March
GEROPHARM was given permission to conduct clinical trials of insulin analogue glargine
Subscribe to the newsletter
 
1
2
3
4